Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, Basel, Switzerland.
PLoS One. 2019 Aug 29;14(8):e0221762. doi: 10.1371/journal.pone.0221762. eCollection 2019.
BACKGROUND & AIMS: Hepatocyte-like cells (HLCs) differentiated from induced pluripotent stem cells (iPSCs) have emerged as a promising cell culture model to study metabolism, biotransformation, viral infections and inherited liver diseases. iPSCs provide an unlimited supply for the generation of HLCs, but incomplete HLC differentiation remains a major challenge. iPSC may carry-on a tissue of origin dependent expression memory influencing iPSC differentiation into different cell types. Whether liver derived iPSCs (Li-iPSCs) would allow the generation of more fully differentiated HLCs is not known.
In the current study, we used primary liver cells (PLCs) expanded from liver needle biopsies and reprogrammed them into Li-iPSCs using a non-integrative Sendai virus-based system. Li-iPSCs were differentiated into HLCs using established differentiation protocols. The HLC phenotype was characterized at the protein, functional and transcriptional level. RNA sequencing data were generated from the originating liver biopsies, the Li-iPSCs, fibroblast derived iPSCs, and differentiated HLCs, and used to characterize and compare their transcriptome profiles.
Li-iPSCs indeed retain a liver specific transcriptional footprint. Li-iPSCs can be propagated to provide an unlimited supply of cells for differentiation into Li-HLCs. Similar to HLCs derived from fibroblasts, Li-HLCs could not be fully differentiated into hepatocytes. Relative to the originating liver, Li-HLCs showed lower expression of liver specific transcription factors and increased expression of genes involved in the differentiation of other tissues.
PLCs and Li-iPSCs obtained from small pieces of human needle liver biopsies constitute a novel unlimited source for the production of HLCs. Despite the preservation of a liver specific gene expression footprint in Li-iPSCs, the generation of fully differentiated hepatocytes cannot be achieved with the current differentiation protocols.
诱导多能干细胞(iPSCs)分化而来的肝细胞样细胞(HLCs)已成为研究代谢、生物转化、病毒感染和遗传性肝病的有前途的细胞培养模型。iPSCs 为 HLC 的产生提供了无限的供应,但不完全的 HLC 分化仍然是一个主要挑战。iPSC 可能会保留组织来源相关的表达记忆,影响 iPSC 分化为不同的细胞类型。肝来源的 iPSCs(Li-iPSCs)是否能够产生更完全分化的 HLCs 尚不清楚。
在本研究中,我们使用从肝针活检中扩增的原代肝细胞(PLCs),并使用非整合性 Sendai 病毒系统将其重编程为 Li-iPSCs。使用已建立的分化方案将 Li-iPSCs 分化为 HLCs。在蛋白质、功能和转录水平上对 HLC 表型进行了特征描述。从原始肝活检、Li-iPSCs、成纤维细胞衍生的 iPSCs 和分化的 HLCs 生成 RNA 测序数据,并用于表征和比较它们的转录组图谱。
Li-iPSCs 确实保留了肝脏特异性转录足迹。Li-iPSCs 可以繁殖,为分化为 Li-HLCs 提供无限的细胞供应。与源自成纤维细胞的 HLCs 相似,Li-HLCs 不能完全分化为肝细胞。与起源肝脏相比,Li-HLCs 肝脏特异性转录因子的表达较低,而参与其他组织分化的基因表达增加。
从小部分人类肝针活检中获得的 PLCs 和 Li-iPSCs 构成了产生 HLC 的新型无限来源。尽管 Li-iPSCs 中保留了肝脏特异性基因表达足迹,但当前的分化方案无法产生完全分化的肝细胞。